Homéomunyl Influenzinum 9CH Boiron Doses – Flu-Like States – From Age 6+ (2025–2026 Strain)

For: Children (6+), Teenagers, Adults
Pregnancy: Allowed
Breastfeeding: Allowed
Form: Single-dose granules (unidose)
Pack Size: 4 unidoses

Description

Homéomunyl by Boiron is a homeopathic medicine traditionally used for the prevention of flu-like states.
Each unidose contains Influenzinum 9CH, a preparation derived from the current year’s influenza vaccine strain (2025–2026).

While Homéomunyl is not a vaccine, it is prepared from the influenza vaccine of the season. The Influenzinum strain is updated annually based on the flu viruses expected to circulate most frequently. The preparation undergoes successive dilutions and dynamizations, in this case to the 9CH potency (meaning nine centesimal dilutions following Hahnemann’s homeopathic method).

The active ingredient Influenzinum 9CH is supported by inactive ingredients lactose monohydrate and sucrose.

Directions for Use

• Take one unidose per week for three consecutive weeks starting in early autumn.

• Take the fourth dose one month after the third.

• Empty the contents of one unidose under the tongue in the morning, preferably on an empty stomach or away from meals.

• Let the granules dissolve slowly; do not swallow them whole.

Precautions

• Not recommended for children under 6 years old.

• Do not use in case of known allergy to any of the ingredients.

• Do not use if you have congenital galactosemia, glucose-galactose malabsorption, or lactase deficiency (due to lactose content).

• Do not use if you have fructose intolerance or sucrase-isomaltase deficiency (due to sucrose content).

• Always inform your doctor or pharmacist about any other medications you are taking, even over-the-counter ones.

• During pregnancy or breastfeeding, consult your doctor or pharmacist before use.

Key Features

• Homeopathic flu prevention support

• Updated with the 2025–2026 influenza strain

• Suitable for adults and children aged 6+

• Safe for use during pregnancy and breastfeeding

• 4 single-use doses per box

Manufacturer: Boiron
Origin: France

Please read the following full disclosure before purchasing or using this product.

SUMMARY OF PRODUCT CHARACTERISTICS

ANSM – Updated: September 2, 2024

1. NAME OF THE MEDICINAL PRODUCT

Homéomunyl, granules in single-dose container.

2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Influenzinum 9CH ...................................................................................... 0.01 ml
(for 1 g of granules in a single-dose container)

Excipient(s) with known effect: lactose and sucrose.
For the complete list of excipients, see section 6.1.

3. PHARMACEUTICAL FORM

Granules in a single-dose container.

4. CLINICAL PARTICULARS

4.1. Therapeutic indications
Homeopathic medicine traditionally used for the prevention of flu-like states.

4.2. Posology and method of administration
This medicine is intended for adults and children over 6 years old.

Dosage
At the beginning of autumn, take one dose per week for three weeks, then the fourth dose one month after the third dose.

Method of administration
Sublingual route.
Allow the entire contents of one single-dose container to dissolve under the tongue in the morning on an empty stomach, or preferably away from meals.

4.3. Contraindications

• Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.

• Children under 6 years of age.

4.4. Special warnings and precautions for use

• This medicine is not a vaccine.

• Homeopathic treatment does not replace any specific medical treatment that may be necessary.

This medicine contains lactose. Its use is not recommended in patients with galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption syndrome.

This medicine also contains sucrose. Its use is not recommended in patients with fructose intolerance, glucose-galactose malabsorption syndrome, or sucrase-isomaltase deficiency.

4.5. Interaction with other medicinal products and other forms of interaction
Not applicable.

4.6. Fertility, pregnancy, and lactation
Not applicable.

4.7. Effects on ability to drive and use machines
Not applicable.

4.8. Undesirable effects
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorization of the medicine is important. It allows continued monitoring of the benefit/risk balance of the product.
Healthcare professionals should report any suspected adverse reactions via the national reporting system:
Agence nationale de sécurité du médicament et des produits de santé (ANSM) and the network of Regional Pharmacovigilance Centers – Website: https://signalement.social-sante.gouv.fr/

4.9. Overdose
Not applicable.

5. PHARMACOLOGICAL PROPERTIES

5.1. Pharmacodynamic properties
Pharmacotherapeutic class: Homeopathic medicine.
In the absence of clinical trials, the indication of this product is based on its traditional homeopathic use.

5.2. Pharmacokinetic properties
Not applicable.

5.3. Preclinical safety data
Not applicable.

6. PHARMACEUTICAL PARTICULARS

6.1. List of excipients
Lactose and sucrose.

6.2. Incompatibilities
Not applicable.

6.3. Shelf life
12 months.

6.4. Special precautions for storage
No special storage precautions required.

6.5. Nature and contents of the outer packaging
Box of 4 single-dose containers (polypropylene/polyethylene) of 1 g each.

6.6. Special precautions for disposal and handling
Not applicable.

7. MARKETING AUTHORISATION HOLDER

BOIRON
2 Avenue de l’Ouest Lyonnais
69510 Messimy, France

8. MARKETING AUTHORISATION NUMBER(S)

34009 357 475 3 2 – Granules in single-dose containers (PP/PE). Box of 4.

9. DATE OF FIRST AUTHORISATION / RENEWAL OF THE AUTHORISATION

[To be completed later by the holder]

10. DATE OF REVISION OF THE TEXT

[To be completed later by the holder]

11. DOSIMETRY

Not applicable.

12. INSTRUCTIONS FOR THE PREPARATION OF RADIOPHARMACEUTICALS

Not applicable.